Editing Merck Group (section)

====Merck consumer-health====
In September 2017, Merck said it is considering options for its consumer-health division, including a potential full or partial sale, or strategic partnership. An [[equity analyst]] estimated the unit could command a purchase price of €1.8 billion to €2.7 billion from a full sale.<ref>{{cite news|last1=Roland|first1=Denise|title=Germany's Merck Puts Consumer Drugs Business on the Block|url=https://www.wsj.com/articles/germanys-merck-puts-consumer-drugs-business-on-the-block-1504616461|access-date=5 September 2017|work=Wall Street Journal|date=5 September 2017}}</ref> In December ''[[Reuters]]'' reported that both [[Nestlé]] and private equity owners of [[Stada Arzneimittel|Stada]]<ref>{{Cite news | url=https://www.reuters.com/article/us-merck-m-a-nestle/nestle-stada-prepare-rival-bids-for-germanys-merck-consumer-health-sources-idUSKBN1DV5R3 | title=Nestle, Stada prepare rival bids for Germany's Merck consumer| newspaper=Reuters| date=December 2017}}</ref> were preparing bids for Merck's consumer health group. Days later, Reuters again reported that [[Perrigo]] was also preparing a bid for the division in the region of €4 billion ($4.7 billion to $4.8 billion).<ref>{{Cite news | url=https://uk.reuters.com/article/us-merck-m-a-perrigo-company/perrigo-lines-up-bid-for-mercks-consumer-health-unit-sources-idUKKBN1E82OF | archive-url=https://web.archive.org/web/20171214212022/https://uk.reuters.com/article/us-merck-m-a-perrigo-company/perrigo-lines-up-bid-for-mercks-consumer-health-unit-sources-idUKKBN1E82OF | url-status=dead | archive-date=14 December 2017 | title=Perrigo lines up bid for Merck's consumer health unit: Sources| newspaper=Reuters| date=14 December 2017}}</ref> In April 2018, Reuters reported that generic drug manufacturer, [[Mylan]] was in advanced discussions to acquire the consumer health business for between  €3.5–4 billion (£3–3.4 billion).<ref>{{Cite news | url=https://uk.reuters.com/article/uk-merck-consumer-health-mylan/mylan-seeks-deal-for-german-mercks-consumer-products-unit-sources-idUKKBN1HK12L | title=Mylan seeks deal for German Merck's consumer products unit: Sources| newspaper=Reuters| date=13 April 2018}}{{dead link|date=September 2024|bot=medic}}{{cbignore|bot=medic}}</ref> Later in the month, Reuters reported that [[Procter & Gamble]] would purchase the division for €3.4 billion euros (£2.96 billion; $4.2 billion).<ref>{{Cite news | url=https://uk.reuters.com/article/uk-merck-m-a-p-g/pg-to-buy-german-mercks-consumer-health-unit-for-4-2-billion-idUKKBN1HQ0EH | archive-url=https://web.archive.org/web/20180419125143/https://uk.reuters.com/article/uk-merck-m-a-p-g/pg-to-buy-german-mercks-consumer-health-unit-for-4-2-billion-idUKKBN1HQ0EH | url-status=dead | archive-date=19 April 2018 | title=P&G to buy German Merck's consumer health unit for $4.2 billion| newspaper=Reuters| date=23 April 2018}}</ref>